FORMULATIONS OF FENOFIBRATE AND/OR FENOFIBRATE DERIVATIVES WITH IMPROVED ORAL BIOAVAILABILITY
摘要
<p>A fibrate oral formulation with improved bioavailability when compared to commercially available formulations containing a therapeutically effective dose of fenofibrate or a fenofibrate derivative dissolved in N-alkyl derivative of 2-pyrrolidone, ethylene glycol monoether, C8-12 fatty acid ester of polyethylene glycol, fatty acids, or combinations thereof useful for the treatment of hypercholesterolaemia or hypertriglyceridaemia in mammals.</p>
申请公布号
WO2004002458(A1)
申请公布日期
2004.01.08
申请号
WO2002US41093
申请日期
2002.12.20
申请人
SHIRE LABORATORIES INC.;SHOJAEI, AMIR, H.;IBRAHIM, SCOTT, A.;BURNSIDE, BETH, A.
发明人
SHOJAEI, AMIR, H.;IBRAHIM, SCOTT, A.;BURNSIDE, BETH, A.